Viewing Study NCT02189603


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2026-01-02 @ 9:40 AM
Study NCT ID: NCT02189603
Status: COMPLETED
Last Update Posted: 2018-08-17
First Post: 2014-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine(Hecolin®)
Sponsor: Jun Zhang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module